Older COVID-19 survivors face increased Alzheimer’s risk, study finds

It is still unclear whether COVID-19 is hastening the progression of pre-existing neurodegeneration or prompting new disease

A new study tracking the health of more than six million older Americans over 2020 and 2021 has found COVID-19 nearly doubles a person’s risk of developing Alzheimer’s disease in the year following infection. The findings add to a growing body of research indicating SARS-CoV-2 infections can affect progression of several neurodegenerative diseases.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , , , ,

Continue reading Older COVID-19 survivors face increased Alzheimer’s risk, study finds

New evidence affirms link between long COVID and chronic fatigue syndrome

A new study published in Nature Communications has added to the growing body of evidence reporting similarities between long COVID and chronic fatigue syndrome (ME/CFS). The research found around half of the long COVID patients studied fit the diagnost… Continue reading New evidence affirms link between long COVID and chronic fatigue syndrome

New evidence affirms link between long COVID and chronic fatigue syndrome

A new study published in Nature Communications has added to the growing body of evidence reporting similarities between long COVID and chronic fatigue syndrome (ME/CFS). The research found around half of the long COVID patients studied fit the diagnost… Continue reading New evidence affirms link between long COVID and chronic fatigue syndrome

Omicron COVID vaccine booster authorized in US, roll-out begins in days

The US Food and Drug Administration (FDA) has authorized new mRNA vaccine booster shots targeting the BA.4 and BA.5 Omicron variant of SARS-CoV-2. The authorization marks the first updated COVID-19 vaccines to be made available in the United States sin… Continue reading Omicron COVID vaccine booster authorized in US, roll-out begins in days

Concrete made with shredded PPE gear offers up to 22% higher strength

Scientists continue to make promising inroads around more durable forms of concrete, and engineers at Melbourne’s RMIT University have been operating at the cutting edge of this research for some time. Their latest example simultaneously tackles the mo… Continue reading Concrete made with shredded PPE gear offers up to 22% higher strength

Antibody “master key” discovery could neutralize all COVID variants

A new study published in Nature Communications has homed in on a part of the SARS-CoV-2 spike protein that seems to be shared across all known variants. The research also reveals an antibody fragment that can hypothetically block the virus from enterin… Continue reading Antibody “master key” discovery could neutralize all COVID variants

Oxford study finds increased dementia risk 2 years after COVID infection

New research is some of the first to look at the long-term effects of a COVID infection up to two years after the acute illness

New research published in The Lancet Psychiatry has offered the most comprehensive look at the long-term neurological effects of COVID-19 published to date, tracking more than one million people for up to two years. The findings revealed an increased risk of mood disorders such as depression and anxiety, following SARS-CoV-2 infection, returns to normal after a few months but increased rates of dementia are still being detected in older adults up to 24 months after the acute disease.

Continue Reading

Category: Health & Wellbeing, Lifestyle

Tags: , , , , , ,

Continue reading Oxford study finds increased dementia risk 2 years after COVID infection

UK approves BA.1 vaccines while US still waits for BA.5 boosters

Regulators in the United Kingdom have approved Moderna’s new Omicron-specific COVID-19 vaccine for an upcoming nation-wide autumn booster program. The approval makes the UK the first region in the world to formally move forward with an improved variant… Continue reading UK approves BA.1 vaccines while US still waits for BA.5 boosters

UK approves BA.1 vaccines while US still waits for BA.5 boosters

Regulators in the United Kingdom have approved Moderna’s new Omicron-specific COVID-19 vaccine for an upcoming nation-wide autumn booster program. The approval makes the UK the first region in the world to formally move forward with an improved variant… Continue reading UK approves BA.1 vaccines while US still waits for BA.5 boosters

MIT develops rapid at-home test to measure COVID immunity

An innovative new test developed by researchers at MIT promises to offer people the ability to quickly and easily measure their COVID-19 immunity. The test tracks levels of neutralizing antibodies in a drop of blood, helping a person evaluate their sus… Continue reading MIT develops rapid at-home test to measure COVID immunity